Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
PROXEON BIOSYSTEMS ApS
APS
Active
CVR 26848024
Kamstrupvej 90, 4000
Roskilde
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2002 · 23 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PROXEON BIOSYSTEMS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
49M
36M
24M
12M
0M
2021: 31M
31M
2021
2022: 39M (+26% vs 2021)
39M
+26%
2022
2023: 37M (-5% vs 2022)
37M
-5%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
EBITDA
DKK millions
49M
36M
24M
12M
0M
2021: 31M
31M
2021
2022: 39M (+26% vs 2021)
39M
+26%
2022
2023: 37M (-5% vs 2022)
37M
-5%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
0
0
36.919
39.387
30.910
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-279
-403
36.617
39.123
30.708
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-279
-403
36.617
39.123
30.708
Net financials
4.110
8.159
4.733
-98
-26
Profit before tax
3.831
7.756
41.350
39.025
30.682
Tax
881
4.053
48.782
8.632
6.750
Net profit
2.950
3.703
-7.432
30.393
23.932
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
387.551
394.523
389.132
387.442
363.853
Equity
386.590
383.640
379.937
387.369
356.976
Long-term debt
0
0
0
0
0
Short-term debt
961
10.883
9.195
73
6.877
Total debt
961
10.883
9.195
73
6.877
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
99,8 %
This company
38,2 %
Market median
This company
Market median
161% above market
2021
2025
Return on equity
0,8 %
This company
18,4 %
Market median
This company
Market median
96% below market
2021
2025
Net profit margin (of gross profit)
>999 %
This company
2021
2025
Asset turnover (of gross profit)
0,00×
This company
2021
2025
Debt / equity
0,00×
This company
0,62×
Market median
This company
Market median
100% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on PROXEON BIOSYSTEMS ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
